Bundesministerium für Bildung und Forschung (BMBF)
This sponsor has funded 3 studies across 4 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 7892 | Planned | An immune therapy register for the improvement of drug safety and treatment of patients with Multiple Sclerosis (REGIMS) | No | No |
| 36582 | Ongoing | Overarching Use Case of the German Medical Informatics Initiative MII “POLAR_MI – POLypharmacy, Drug interActions, Risks” | No | No |
| 42767 | Ongoing | The European HBV Registry: A joint initiative of TherVacB and DZIF (HBV Registry) | No | No |
PAS by Risk Management Plan (RMP) requirement
Bundesministerium für Bildung und Forschung (BMBF)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
Bundesministerium für Bildung und Forschung (BMBF)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
Bundesministerium für Bildung und Forschung (BMBF)
4 Study countries specified are the following:
- Germany
- Italy
- Spain
- United Kingdom